Meet the finalist | Dr Jonathan Evans RSM Coloproctology Section Presentation title: The Nrf2 inhibitor Brusatol is a potent antitumour agent, and enhances irinotecan cytotoxicity, in an orthotopic mouse model of colorectal cancer. Focus on colorectal cancer Currently a specialist trainee in general surgery, with a sub-specialty interest in colorectal, Dr Jonathan Evans studied medicine at the University of Liverpool. […]
Read More… from Wesleyan RSM trainee of the year finalist: Dr Jonathan Evans